879 related articles for article (PubMed ID: 7793988)
1. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
2. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
[TBL] [Abstract][Full Text] [Related]
3. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease.
Narindrasorasak S; Altman RA; Gonzalez-DeWhitt P; Greenberg BD; Kisilevsky R
Lab Invest; 1995 Mar; 72(3):272-82. PubMed ID: 7898047
[TBL] [Abstract][Full Text] [Related]
4. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
5. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
6. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
7. Large matrix proteoglycans, versican and perlecan, are expressed and secreted by human leukemic monocytes.
Makatsori E; Lamari FN; Theocharis AD; Anagnostides S; Hjerpe A; Tsegenidis T; Karamanos NK
Anticancer Res; 2003; 23(4):3303-9. PubMed ID: 12926067
[TBL] [Abstract][Full Text] [Related]
8. Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds.
Leveugle B; Scanameo A; Ding W; Fillit H
Neuroreport; 1994 Jun; 5(11):1389-92. PubMed ID: 7522615
[TBL] [Abstract][Full Text] [Related]
9. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins.
Narindrasorasak S; Lowery DE; Altman RA; Gonzalez-DeWhitt PA; Greenberg BD; Kisilevsky R
Lab Invest; 1992 Nov; 67(5):643-52. PubMed ID: 1434542
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
Multhaup G; Mechler H; Masters CL
J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
[TBL] [Abstract][Full Text] [Related]
11. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin.
Gauer S; Schulze-Lohoff E; Schleicher E; Sterzel RB
Eur J Cell Biol; 1996 Jul; 70(3):233-42. PubMed ID: 8832207
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate proteoglycans in the substratum adhesion sites of human neuroblastoma cells: modulation of affinity binding to fibronectin.
Vallen EA; Eldridge KA; Culp LA
J Cell Physiol; 1988 May; 135(2):200-12. PubMed ID: 2967301
[TBL] [Abstract][Full Text] [Related]
13. Proteoglycans of human umbilical cord arteries.
Gogiel T; Jaworski S
Acta Biochim Pol; 2000; 47(4):1081-91. PubMed ID: 11996098
[TBL] [Abstract][Full Text] [Related]
14. Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin.
Tsara ME; Theocharis AD; Theocharis DA
Anticancer Res; 2002; 22(5):2893-8. PubMed ID: 12530013
[TBL] [Abstract][Full Text] [Related]
15. Perlecan in the basement membrane of corneal epithelium serves as a site for P. aeruginosa binding.
Chen LD; Hazlett LD
Curr Eye Res; 2000 Apr; 20(4):260-7. PubMed ID: 10806439
[TBL] [Abstract][Full Text] [Related]
16. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.
Talts JF; Andac Z; Göhring W; Brancaccio A; Timpl R
EMBO J; 1999 Feb; 18(4):863-70. PubMed ID: 10022829
[TBL] [Abstract][Full Text] [Related]
17. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: the proteoglycans hypothesis.
Celesia GG
Semin Thromb Hemost; 1991; 17 Suppl 2():158-60. PubMed ID: 1948087
[No Abstract] [Full Text] [Related]
19. Distinct rat aortic smooth muscle cells differ in versican/PG-M expression.
Lemire JM; Potter-Perigo S; Hall KL; Wight TN; Schwartz SM
Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):821-9. PubMed ID: 8640411
[TBL] [Abstract][Full Text] [Related]
20. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
